Home

DELPHI BIOINVESTMENTS VI LP

CIK 1241073 · last filed 2011-09-23

DELPHI BIOINVESTMENTS VI LP is a corporate insider who has filed 4 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing shows the insider bought $30.0M of TSON on Sep 23, 2011. Across all open-market trades the lifetime net is +$32.4M, making them a net buyer over the disclosed history. The firm reports its address in Menlo Park, CA. 13 SEC filings were submitted jointly with DELPHI MANAGEMENT PARTNERS VI LLC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

4

Lifetime Open-Market Net

$32.36M

Filer Profile

Reported Address
3000 SAND HILL ROAD, BLDG 1, STE 135
C/O DELPHI VENTURES
MENLO PARK, CA 94025
Phone
(650) 854-9650
State of Incorporation
DE
Related Filers
DELPHI MANAGEMENT PARTNERS VI LLC — 13 joint filings, latest 2011-09-23
DELPHI VENTURES VI LP — 13 joint filings, latest 2011-09-23
JAMES J BOCHNOWSKI — 7 joint filings, latest 2009-10-20
DAVID L DOUGLASS — 7 joint filings, latest 2009-10-20
JOHN F MARONEY — 7 joint filings, latest 2009-10-20
DEEPIKA PAKIANATHAN — 7 joint filings, latest 2009-10-20
DOUGLAS A ROEDER — 7 joint filings, latest 2009-10-20
DELPHI VENTURES VIII LP — 1 joint filings, latest 2011-09-23
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BAXANO SURGICAL, INC. (TSON) Delisted 10%+ Owner 2,236,272 — — $32.36M 3 2011-09-23
Seagen Inc. (SGEN) Delisted 10%+ Owner 3,980,200 $228.74 $910.43M $0 1 2007-01-19

Recent Filings

4 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2011-09-23 BAXANO SURGICAL, INC. (TSON) Delisted Buy (P) +9,230,766 $30.00M EDGAR
2009-09-22 BAXANO SURGICAL, INC. (TSON) Delisted — — $0 EDGAR
2009-03-03 BAXANO SURGICAL, INC. (TSON) Delisted Buy (P) +400,000 $2.36M EDGAR
2007-01-19 Seagen Inc. (SGEN) Delisted Conv (C) +6,000,000 $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.